Related Experiment Video

Updated: Sep 20, 2026

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection
05:57

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection

Published on: February 10, 2017

Caustic esophageal lesions in childhood: prevention of stricture formation

F A Wijburg1, H S Heymans, N A Urbanus

  • 1Department of Pediatrics, University Hospital of Amsterdam (AMC), The Netherlands.

Journal of Pediatric Surgery
|February 1, 1989
PubMed

Insights

A novel nasogastric tube stent effectively prevents esophageal strictures after caustic ingestion in children. This treatment avoids corticosteroids and reduces hospitalization, offering a safe and effective solution for pediatric caustic esophageal injuries.

Area of Science:

  • Pediatric Gastroenterology
  • Otolaryngology
  • Emergency Medicine

Background:

  • Accidental caustic ingestion is a significant cause of esophageal stricture in children.
  • Deep and circular esophageal burns increase the risk of long-term complications.

Purpose of the Study:

  • To evaluate the efficacy of a nasogastric tube functioning as an intraluminal stent in preventing esophageal stricture formation after caustic ingestion in pediatric patients.
  • To assess the necessity of corticosteroid use in managing these injuries.

Main Methods:

  • A cohort of 132 children under 19 with suspected caustic ingestion was studied.
  • Eleven children with deep, circular esophageal burns were treated with a nasogastric tube stent as their sole intervention.
  • No corticosteroids were administered to the treated group.

Main Results:

  • Only one of the 11 treated children developed mild stenosis.
  • No esophageal strictures were observed in the untreated children.
  • The nasogastric tube stent proved effective in preventing stricture formation.

Conclusions:

  • A nasogastric tube intraluminal stent is an effective method for preventing esophageal strictures in children following caustic ingestion.
  • This approach can reduce unnecessary treatment and hospitalizations.
  • Corticosteroids are not required for managing pediatric caustic esophageal lesions when using this stenting technique.

More Related Videos

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function09:40

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Published on: April 17, 2020

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...